0001209191-19-030613.txt : 20190516
0001209191-19-030613.hdr.sgml : 20190516
20190516184228
ACCESSION NUMBER: 0001209191-19-030613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190515
FILED AS OF DATE: 20190516
DATE AS OF CHANGE: 20190516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHAFER CAROL
CENTRAL INDEX KEY: 0001272181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 19833725
MAIL ADDRESS:
STREET 1: 42 WHITE STREET, FOURTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-15
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001272181
SCHAFER CAROL
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
9.17
2019-05-15
4
A
0
25000
0.00
A
2029-05-14
Common Stock
25000
25000
D
The shares underlying this option vest at a rate of one-third per year on each anniversary of May 15, 2019, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through each such date.
/s/ Francis Sarena, Attorney-in-fact
2019-05-16